Cameron Groome
Chief Executive Officer chez MICROBIX BIOSYSTEMS INC.
Fortune : 743 576 $ au 31/03/2024
Profil
Mr. Cameron L.
Groome is an Independent Director at iFabric Corp.
and a President, Chief Executive Officer & Director at Microbix Biosystems, Inc. He is on the Board of Directors at iFabric Corp.
and Microbix Biosystems, Inc. Mr. Groome was previously employed as a President, Chief Executive Officer & Director by Avivagen, Inc., an Executive VP-Corporate & Strategic Development by Bioniche Life Sciences, Inc., and an Analyst by National Bank Financial, Inc. (Broker).
He also served on the board at ScarX Therapeutics, Inc. He received his undergraduate degree from Concordia University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC.
1,94% | 23/02/2024 | 2 645 500 ( 1,94% ) | 719 576 $ | 31/03/2024 |
IFABRIC CORP.
0,08% | 05/02/2024 | 25 000 ( 0,08% ) | 24 000 $ | 31/03/2024 |
Postes actifs de Cameron Groome
| Sociétés | Poste | Début |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Chief Executive Officer | 24/07/2017 |
| IFABRIC CORP. | Director/Board Member | 30/03/2020 |
Anciens postes connus de Cameron Groome
| Sociétés | Poste | Fin |
|---|---|---|
ScarX Therapeutics, Inc.
 ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Director/Board Member | 01/03/2018 |
| AVIVAGEN INC. | Chief Executive Officer | 09/02/2017 |
| TELESTA THERAPEUTICS INC | Corporate Officer/Principal | 30/07/2012 |
National Bank Financial, Inc. (Broker)
 National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Analyst-Equity | 14/05/2002 |
Formation de Cameron Groome
| Concordia University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| AVIVAGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
National Bank Financial, Inc. (Broker)
National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Finance |
| iFabric Corp. | |
ScarX Therapeutics, Inc.
ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Health Technology |
